Core Scientific (NASDAQ:CORZ) Price Target Cut to $23.75 by Analysts at LADENBURG THALM/SH SH

Core Scientific (NASDAQ:CORZFree Report) had its price target decreased by LADENBURG THALM/SH SH from $24.50 to $23.75 in a research report report published on Tuesday,Benzinga reports. LADENBURG THALM/SH SH currently has a buy rating on the stock.

Other analysts have also recently issued reports about the stock. Citizens Jmp raised shares of Core Scientific from a “market perform” rating to an “outperform” rating and set a $30.00 price target for the company in a research report on Thursday, December 18th. Sanford C. Bernstein boosted their target price on shares of Core Scientific from $17.00 to $24.00 and gave the stock an “outperform” rating in a research report on Monday, November 3rd. BTIG Research raised Core Scientific from a “neutral” rating to a “buy” rating and set a $23.00 price target on the stock in a research report on Tuesday, January 6th. Weiss Ratings restated a “sell (d-)” rating on shares of Core Scientific in a research note on Wednesday, January 21st. Finally, Keefe, Bruyette & Woods upped their price target on shares of Core Scientific from $19.00 to $25.00 and gave the stock a “moderate buy” rating in a research report on Tuesday, January 27th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating, three have issued a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, Core Scientific has an average rating of “Moderate Buy” and an average target price of $24.66.

Check Out Our Latest Research Report on Core Scientific

Core Scientific Stock Down 7.2%

Shares of CORZ stock opened at $15.30 on Tuesday. The stock has a market cap of $4.74 billion, a P/E ratio of 13.08 and a beta of 6.87. The business has a fifty day simple moving average of $17.27 and a 200-day simple moving average of $16.96. Core Scientific has a fifty-two week low of $6.20 and a fifty-two week high of $23.63.

Core Scientific (NASDAQ:CORZGet Free Report) last posted its quarterly earnings data on Monday, March 2nd. The company reported $0.42 EPS for the quarter, beating analysts’ consensus estimates of ($0.27) by $0.69. The company had revenue of $79.76 million for the quarter, compared to analyst estimates of $118.45 million. The firm’s revenue was down 16.0% on a year-over-year basis. During the same period in the previous year, the business earned ($0.69) EPS. On average, sell-side analysts anticipate that Core Scientific will post 0.52 earnings per share for the current year.

Institutional Investors Weigh In On Core Scientific

Hedge funds and other institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. raised its position in Core Scientific by 18.7% in the fourth quarter. Vanguard Group Inc. now owns 33,960,320 shares of the company’s stock worth $494,462,000 after purchasing an additional 5,359,710 shares in the last quarter. Situational Awareness LP lifted its position in Core Scientific by 42.5% during the 4th quarter. Situational Awareness LP now owns 28,756,478 shares of the company’s stock valued at $418,694,000 after purchasing an additional 8,575,944 shares during the period. Jericho Capital Asset Management L.P. boosted its stake in Core Scientific by 11.4% in the fourth quarter. Jericho Capital Asset Management L.P. now owns 13,038,619 shares of the company’s stock valued at $189,842,000 after acquiring an additional 1,338,796 shares during the last quarter. Value Aligned Research Advisors LLC bought a new stake in Core Scientific in the fourth quarter valued at about $117,786,000. Finally, Geode Capital Management LLC boosted its stake in Core Scientific by 1.4% during the 4th quarter. Geode Capital Management LLC now owns 7,651,002 shares of the company’s stock worth $111,417,000 after acquiring an additional 109,145 shares during the last quarter.

Key Stories Impacting Core Scientific

Here are the key news stories impacting Core Scientific this week:

  • Positive Sentiment: Unusually large options activity — traders bought ~188,642 call options (≈51% above normal call volume), signalling aggressive bullish positioning from some market participants.
  • Positive Sentiment: Colocation revenue surge — management reported colocation revenue grew dramatically (reported +268% year-over-year), supporting the company’s transition from BTC mining toward AI/colocation demand. Core Scientific Colocation Revenue Surges 268% Amid Mixed Q4 Results
  • Positive Sentiment: Analyst upgrades and high targets — Needham upgraded CORZ to Buy with a $23 target (~+50% implied upside), HC Wainwright reaffirmed Buy with $25, and Cantor Fitzgerald kept an Overweight with a $25 target; these actions reinforce a bullish analyst tone despite some target trims. Needham Upgrade
  • Neutral Sentiment: Mixed quarter — CORZ reported $0.42 EPS (beat consensus) but revenue of $79.8M missed estimates (~$118M), so profitability signals improved while top-line momentum is weak; management emphasized progress on a 1.5 GW leasable pipeline. Business Wire: Q4 Results
  • Neutral Sentiment: Full disclosure and detail sources — earnings slide deck and call transcript are available for investors who want to dig into guidance, margin dynamics, and contract backlog. Earnings Presentation
  • Negative Sentiment: Revenue miss and reported loss — some outlets highlight the Q4 revenue miss and a quarterly loss (Zacks coverage), raising near-term concern about top-line pacing while the company reinvests for AI/colocation growth. Zacks: Q4 Loss, Revenue Miss
  • Negative Sentiment: Immediate market reaction — coverage notes CORZ shares slid after the report and as the company pushes a sizable infrastructure expansion (1.5 GW), highlighting investor worry about near-term cash burn and execution risk. Blockonomi: Stock Slides
  • Neutral Sentiment: Short-interest data appears unreliable in recent feeds (showing zeros/NaN); no clear short-squeeze signal from public short-interest figures at this time.

Core Scientific Company Profile

(Get Free Report)

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.

Featured Stories

Analyst Recommendations for Core Scientific (NASDAQ:CORZ)

Receive News & Ratings for Core Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Scientific and related companies with MarketBeat.com's FREE daily email newsletter.